EUDA Health Holdings Ltd

EUDA Health Holdings Ltd(EUDA)股票分析

$13.870

-0.889 (-6.41%)收盤時

Loading chart…
最高
16.009
開盤
15.350
成交量加權均價
14.46
成交量
28.84K
市值
146.48M
最低
13.510
成交金額
417.13K
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

EUDA Health Holdings Limited is a health technology company. The Company operates a southeast Asian digital healthcare ecosystem. Its unified artificial intelligence platform assesses patients' medical history, triages conditions, digitally connects patients with clinicians, and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. Its medical urgent care services provide healthcare assistance and medical evacuation to individual and corporate clients. Its property management service covers the management of properties, such as condominiums and shopping malls. Its services include e-triage, GP consult, e-medical certificates, and medical prescriptions. Its EUDA platform provides medical services from primary to post-surgery care and ongoing preventive healthcare for clients, regardless of the level of healthcare required.

AI 分析 of EUDA Health Holdings Ltd (EUDA)

買進

EUDA Health Holdings appears to be a good buy right now due to its recent recovery in Nasdaq compliance, which can enhance investor confidence. The stock is currently priced at $15.57, significantly lower than its 52-week high of $71.20, indicating potential for upside. Additionally, the stock has shown a 5-day change of +7.68%, suggesting a positive short-term trend. However, the main risk is its YTD change of -68.35%, indicating significant volatility and the need for careful monitoring.

估值指標

EUDA Health Holdings Ltd(EUDA)目前預期本益比為 7.81,5 年平均預期本益比為 -6.75。

預期本益比

合理
5 年均值 P/E
-6.75
目前P/E
7.81
高估
21.27
低估
-34.77

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-4.08
目前EV/EBITDA
0.00
高估
1.31
低估
-9.47

預期股價營收比

低估
5 年均值 P/S
6.69
目前P/S
0.00
高估
12.36
低估
1.03

事件時間軸

2026-07-30 (ET)

08:00:00

EUDA Health Signs MOU with GO POSB to Advance Cell Therapy

2026-07-28 (ET)

06:30:00

EUDA Health Signs Tripartite MOU with GO POSB for Next-Gen Therapies

2026-07-14 (ET)

10:30:00

EUDA Health Holdings Ltd Trading Halted Due to Volatility

2026-05-06 (ET)

09:40:00

EUDA Health Holdings Ltd Trading Halted Due to Volatility Trading Pause

2026-04-29 (ET)

10:00:00

EUDA Health Holdings Ltd Trading Halted Due to Volatility

資訊

EUDA 常見問題 —— 由 Alphio AI 解答

EUDA Health Holdings Limited is a health technology company. The Company operates a southeast Asian digital healthcare ecosystem. Its unified artificial intelligence platform assesses patients' medical history, triages conditions, digitally connects patients with clinicians, and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. Its medical urgent care services provide healthcare assistance and medical evacuation to individual and corporate clients. Its property management service covers the management of properties, such as condominiums and shopping malls. Its services include e-triage, GP consult, e-medical certificates, and medical prescriptions. Its EUDA platform provides medical services from primary to post-surgery care and ongoing preventive healthcare for clients, regardless of the level of healthcare required. It operates in the Industrials sector (SERVICES-HEALTH SERVICES industry).

EUDA Health Holdings appears to be a good buy right now due to its recent recovery in Nasdaq compliance, which can enhance investor confidence. The stock is currently priced at $15.57, significantly lower than its 52-week high of $71.20, indicating potential for upside. Additionally, the stock has shown a 5-day change of +7.68%, suggesting a positive short-term trend. However, the main risk is its YTD change of -68.35%, indicating significant volatility and the need for careful monitoring.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易